{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:33:37Z","timestamp":1790044417965,"version":"4.0.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12888-016-0909-3","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T20:53:57Z","timestamp":1469825637000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":144,"title":["Nonmedical use of prescription drugs in the European Union"],"prefix":"10.1186","volume":"16","author":[{"given":"Scott P.","family":"Novak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"H\u00e5kansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Martinez-Raga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Reimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Krotki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajan","family":"Varughese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"key":"909_CR1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1747-597X-3-22","volume":"3","author":"CJ Boyd","year":"2008","unstructured":"Boyd CJ, McCabe SE. Coming to terms with the nonmedical use of prescription medications. Subst Abuse Treat Prev Policy. 2008;3:22.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"909_CR2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","volume":"36","author":"A Kolodny","year":"2015","unstructured":"Kolodny A, Courtwright DT, Hwang CS, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36:559\u201374.","journal-title":"Annu Rev Public Health"},{"issue":"3 Suppl","key":"909_CR3","doi-asserted-by":"crossref","first-page":"ES9","DOI":"10.36076\/ppj.2012\/15\/ES9","volume":"15","author":"L Manchikanti","year":"2012","unstructured":"Manchikanti L, Helm 2nd S, Fellows B, et al. Opioid epidemic in the United States. Pain Physician. 2012;15(3 Suppl):ES9\u201338.","journal-title":"Pain Physician"},{"key":"909_CR4","unstructured":"ONDCP. Epidemic: Responding to America's prescription drug abuse epidemic. 2012. http:\/\/www.whitehouse.gov\/sites\/default\/files\/ondcp\/policy-and-research\/rx_abuse_plan.pdf . Accessed 15 Jan 2015."},{"key":"909_CR5","unstructured":"Time. Why America can't kick its pain reliever problem. 2015. http:\/\/time.com\/3908648\/why-america-cant-kick-its-painkiller-problem\/ . Accessed 25 Jun 2015."},{"issue":"2","key":"909_CR6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.2011.11030387","volume":"169","author":"SH Zuvekas","year":"2012","unstructured":"Zuvekas SH, Vitiello B. Stimulant medication use in children: a 12-year perspective. Am J Psychiatry. 2012;169(2):160\u20136.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"909_CR7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/AAP.0000000000000022","volume":"39","author":"BD Sites","year":"2014","unstructured":"Sites BD, Beach ML, Davis MA. Increases in the use of prescription opioid analgesics and the lack of improvement in disability metrics among users. Reg Anesth Pain Med. 2014;39(1):6\u201312.","journal-title":"Reg Anesth Pain Med"},{"key":"909_CR8","doi-asserted-by":"crossref","DOI":"10.18356\/12e89c6c-en-fr-es","volume-title":"Narcotic drugs technical report: Estimated world requirements for 2013 - statistics for 2011 (No. T.13.XI.2)","author":"International Narcotic Control Board","year":"2013","unstructured":"International Narcotic Control Board. Narcotic drugs technical report: Estimated world requirements for 2013 - statistics for 2011 (No. T.13.XI.2). New York: International Narcotics Control Board; 2013."},{"issue":"4","key":"909_CR9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10654-009-9321-3","volume":"24","author":"Y Hsia","year":"2009","unstructured":"Hsia Y, Maclennan K. Rise in psychotropic drug prescribing in children and adolescents during 1992\u20132001: a population-based study in the UK. Eur J Epidemiol. 2009;24(4):211\u20136.","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"909_CR10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098405","volume":"9","author":"H Moustgaard","year":"2014","unstructured":"Moustgaard H, Joutsenniemi K, Myrskyla M, Martikainen P. Antidepressant sales and the risk for alcohol-related and non-alcohol-related suicide in Finland--an individual-level population study. PLoS One. 2014;9(6), e98405.","journal-title":"PLoS One"},{"issue":"11","key":"909_CR11","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/j.1360-0443.2006.01566.x","volume":"101","author":"JG Ramaekers","year":"2006","unstructured":"Ramaekers JG, Kuypers KP, Samyn N. Stimulant effects of 3,4-methylenedioxymethamphetamine (MDMA) 75\u00a0mg and methylphenidate 20\u00a0mg on actual driving during intoxication and withdrawal. Addiction. 2006;101(11):1614\u201321.","journal-title":"Addiction"},{"issue":"12","key":"909_CR12","first-page":"1306","volume":"297","author":"KB Mains","year":"2007","unstructured":"Mains KB. Prescription drug abuse rises globally. JAMA. 2007;297(12):1306.","journal-title":"JAMA"},{"key":"909_CR13","volume-title":"Results from the 2013 National Survey on drug use and Health: Summary of National Findings","author":"SAMHSA","year":"2014","unstructured":"SAMHSA. Results from the 2013 National Survey on drug use and Health: Summary of National Findings. Rockville: Substance Abuse and Mental Health Services Administration; 2014."},{"key":"909_CR14","volume-title":"Treatment Episode Data Set (TEDS): 2001\u20132011. State admissions to substance abuse treatment services","author":"SAMHSA","year":"2012","unstructured":"SAMHSA. Treatment Episode Data Set (TEDS): 2001\u20132011. State admissions to substance abuse treatment services. Rockville: Substance Abuse and Mental Health Services Administration; 2012."},{"issue":"2","key":"909_CR15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/ALN.0b013e31817f4523","volume":"109","author":"CL Wu","year":"2008","unstructured":"Wu CL, Agarwal S, Tella PK, et al. Morphine versus mexiletine for treatment of postamputation pain: a randomized, placebo-controlled, crossover trial. Anesthesiology. 2008;109(2):289\u201396.","journal-title":"Anesthesiology"},{"key":"909_CR16","unstructured":"Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System (BRFSS). 2013. http:\/\/www.cdc.gov\/brfss\/ Accessed 17 Feb 2013."},{"key":"909_CR17","unstructured":"Centers for Disease Control and Prevention. National Vital Statistics System: Mortality Data. 2015. http:\/\/www.cdc.gov\/nchs\/deaths.htm . Accessed 3 Aug 2015."},{"key":"909_CR18","unstructured":"RTI. Legalized marijuana in the United States: resulting policy implications. 2015. https:\/\/www.youtube.com\/watch?v=L-TpPPXxC4E . Accessed 23 May 2015."},{"key":"909_CR19","volume-title":"National forensic laboratory information system: midyear report 2014","author":"Drug Enforcement Agency","year":"2015","unstructured":"Drug Enforcement Agency. National forensic laboratory information system: midyear report 2014. Springfield: US Drug Enforcement Agency; 2015."},{"key":"909_CR20","volume-title":"Monitoring the future national results on drug use: key findings on adolescent drug use","author":"LD Johnston","year":"2013","unstructured":"Johnston LD, O\u2019Malley PM, Bachman JG, Schulenberg JE. Monitoring the future national results on drug use: key findings on adolescent drug use. Ann Arbor: Institute for Social Research, The University of Michigan; 2013."},{"key":"909_CR21","unstructured":"European Monitoring Centre for Drugs and Drug Abuse. Data Tables. 2015. http:\/\/www.emcdda.europa.eu\/stats13#display:\/stats13\/gpstab1c . Accessed 24 Mar 2015."},{"issue":"4","key":"909_CR22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jpain.2012.08.008","volume":"14","author":"SF Butler","year":"2013","unstructured":"Butler SF, Cassidy TA, Chilcoat H, et al. Abuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment. J Pain. 2013;14(4):351\u20138.","journal-title":"J Pain"},{"issue":"4","key":"909_CR23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/00952990.2011.569623","volume":"37","author":"NDR Katz","year":"2011","unstructured":"Katz NDR, Bailey E, Trudeau J, Osgood E, Paillard F. Tampering with prescription opioids: nature and extent of the problem, health consequences, and solutions. Am J Drug Alcohol Abuse. 2011;37(4):205\u201317.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"8","key":"909_CR24","first-page":"694","volume":"61","author":"D Musto","year":"1985","unstructured":"Musto D. Iatrogenic addiction: The problem, its definition, and history. Bull NY Acad Med. 1985;61(8):694\u20139.","journal-title":"Bull NY Acad Med"},{"issue":"3","key":"909_CR25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0304-3959(89)90097-3","volume":"36","author":"DE Weissman","year":"1989","unstructured":"Weissman DE, Haddox JD. Opioid pseudoaddiction--an iatrogenic syndrome. Pain. 1989;36(3):363\u20136.","journal-title":"Pain"},{"key":"909_CR26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.drugalcdep.2014.03.002","volume":"138","author":"ER Wright","year":"2014","unstructured":"Wright ER, Kooreman HE, Greene MS, Chambers RA, Banerjee A, Wilson J. The iatrogenic epidemic of prescription drug abuse: county-level determinants of opioid availability and abuse. Drug Alcohol Depen. 2014;138:209\u201315.","journal-title":"Drug Alcohol Depen"},{"key":"909_CR27","unstructured":"EURAD. Alarming rates of prescription drug abuse in the EU. http:\/\/www.eurad.net\/en\/news\/consumption_data\/Alarming+Prescription+Drug+Abuse.9UFRnM1Q.ips . Accessed 20 Nov 2015."},{"issue":"1\u20133","key":"909_CR28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.drugalcdep.2012.11.004","volume":"130","author":"MA Bachhuber","year":"2013","unstructured":"Bachhuber MA, Cunningham CO. Availability of buprenorphine on the Internet for purchase without a prescription. Drug Alcohol Depen. 2013;130(1\u20133):238\u201340.","journal-title":"Drug Alcohol Depen"},{"key":"909_CR29","doi-asserted-by":"crossref","first-page":"d1629","DOI":"10.1136\/bmj.d1629","volume":"342","author":"G Paoli De","year":"2011","unstructured":"De Paoli G, Brandt SD, Pounder DJ. Mephedrone. Banned but still available on the internet. BMJ. 2011;342:d1629.","journal-title":"BMJ"},{"issue":"1\u20132","key":"909_CR30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.drugalcdep.2010.01.015","volume":"110","author":"JASH Inciardi","year":"2010","unstructured":"Inciardi JASH, Cicero TJ, et al. Prescription drugs purchased through the internet: who are the end users? Drug Alcohol Depen. 2010;110(1\u20132):21\u20139.","journal-title":"Drug Alcohol Depen"},{"issue":"4","key":"909_CR31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2307\/2343021","volume":"116","author":"C Moser","year":"1953","unstructured":"Moser C, Stuart A. An experimental study of quota sampling. J Royal Stat Soc. 1953;116(4):349\u2013505.","journal-title":"J Royal Stat Soc"},{"key":"909_CR32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1747-597X-2-32","volume":"2","author":"SP Novak","year":"2007","unstructured":"Novak SP, Kroutil LA, Williams RL, Van Brunt DL. The nonmedical use of prescription ADHD medications: results from a national Internet panel. Subst Abuse Treat Prev Policy. 2007;2:32.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"909_CR33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2307\/2528036","volume":"24","author":"W Cochran","year":"1968","unstructured":"Cochran W. The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics. 1968;24:295\u2013313.","journal-title":"Biometrics"},{"issue":"6","key":"909_CR34","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1213\/01.ANE.0000113547.34160.A5","volume":"98","author":"JC Finkel","year":"2004","unstructured":"Finkel JC, Elrefai A. The use of dexmedetomidine to facilitate opioid and benzodiazepine detoxification in an infant. Anesth Analg. 2004;98(6):1658\u20139.","journal-title":"Anesth Analg"},{"issue":"Suppl 1","key":"909_CR35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mpr.312","volume":"19","author":"J Aldworth","year":"2010","unstructured":"Aldworth J, Colpe LJ, Gfroerer JC, et al. The National survey on drug use and health mental health surveillance study: calibration analysis. Int J Methods Psychiatric Res. 2010;19 Suppl 1:61\u201387.","journal-title":"Int J Methods Psychiatric Res"},{"key":"909_CR36","volume-title":"Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings","author":"SAMHSA","year":"2013","unstructured":"SAMHSA. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. Rockville: Substance Abuse and Mental Health Services Administration; 2013."},{"issue":"13","key":"909_CR37","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","volume":"305","author":"ASVM Bohnert","year":"2011","unstructured":"Bohnert ASVM, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305(13):1315\u201321.","journal-title":"JAMA"},{"issue":"43","key":"909_CR38","first-page":"1487","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","unstructured":"Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008. MMWR Morb Mortal Wkly Rep. 2011;60(43):1487\u201392.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"22","key":"909_CR39","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.2008.802","volume":"300","author":"AJLJ Hall","year":"2008","unstructured":"Hall AJLJ, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300(22):2613\u201320.","journal-title":"JAMA"},{"issue":"2","key":"909_CR40","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1360-0443.2006.01688.x","volume":"102","author":"M Hickman","year":"2007","unstructured":"Hickman M, Carrivick S, Paterson S, et al. London audit of drug-related overdose deaths: characteristics and typology, and implications for prevention and monitoring. Addiction. 2007;102(2):317\u201323.","journal-title":"Addiction"},{"issue":"3","key":"909_CR41","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/10550880903028452","volume":"28","author":"CJ Boyd","year":"2009","unstructured":"Boyd CJ, Teter CJ, West BT, Morales M, McCabe SE. Non-medical use of prescription analgesics: a three-year national longitudinal study. J Addict Dis. 2009;28(3):232\u201342.","journal-title":"J Addict Dis"},{"issue":"5","key":"909_CR42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3200\/JACH.54.5.269-278","volume":"54","author":"SE McCabe","year":"2006","unstructured":"McCabe SE, Teter CJ, Boyd CJ. Medical use, illicit use, and diversion of abusable prescription drugs. J Am Coll Health. 2006;54(5):269\u201378.","journal-title":"J Am Coll Health"},{"issue":"6","key":"909_CR43","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1377\/hlthaff.2011.0155","volume":"30","author":"AB Jena","year":"2011","unstructured":"Jena AB. Growing Internet use may help explain the rise in prescription drug abuse in the United States. Health Aff. 2011;30(6):1192\u20139.","journal-title":"Health Aff"},{"key":"909_CR44","unstructured":"Pew. Internet and American Life Project. 2009. http:\/\/www.pewinternet.org\/Reports\/2009\/Generations-Online-in-2009.aspx . Accessed 20 Nov 2015."},{"key":"909_CR45","unstructured":"Eurostat. Internet usage among EU adults. 2015. https:\/\/ec.europa.eu\/digital-agenda\/en\/news\/internet-usage-individuals-2014 . Accessed 21 Jun 2015."},{"issue":"3\u20134","key":"909_CR46","first-page":"91","volume":"232","author":"F Musshoff","year":"2013","unstructured":"Musshoff F, Hottmann L, Hess C, Madea B. \"Legal highs\" from the German internet--\"bath salt drugs\" on the rise. Arch Kriminol. 2013;232(3\u20134):91\u2013103.","journal-title":"Arch Kriminol"},{"key":"909_CR47","doi-asserted-by":"crossref","first-page":"d1138","DOI":"10.1136\/bmj.d1138","volume":"342","author":"J Sare","year":"2011","unstructured":"Sare J. How the media helped ban mephedrone. BMJ. 2011;342:d1138.","journal-title":"BMJ"},{"issue":"10","key":"909_CR48","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1111\/j.1360-0443.2009.02642.x","volume":"104","author":"R Spijkerman","year":"2009","unstructured":"Spijkerman R, Knibbe R, Knoops K, Van De Mheen D, Van Den Eijnden R. The utility of online panel surveys versus computer-assisted nterviews in obtaining substance-use prevalence estimates in the Netherlands. Addiction. 2009;104(10):1641\u20135.","journal-title":"Addiction"},{"key":"909_CR49","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/002204260103100401","volume":"31","author":"L Richter","year":"2001","unstructured":"Richter L, Johnson PB. Current methods of assessing substance use: a review of strengths, problems, and developments. J Drug Issues. 2001;31:809\u201332.","journal-title":"J Drug Issues"},{"key":"909_CR50","unstructured":"European Monitoring Center for Drugs and Drug Abuse. Table GPS-0. Nationwide surveys among the general population: bibliographic references. http:\/\/www.emcdda.europa.eu\/stats13\/gpstab0 . Accessed 21 July 2015."}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-016-0909-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T12:09:04Z","timestamp":1718712544000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-016-0909-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,4]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["909"],"URL":"https:\/\/doi.org\/10.1186\/s12888-016-0909-3","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,4]]},"article-number":"274"}}